OECD AI principles: Who will implement these and how?

OECD revised its AI principles to regulate booming AI uses and harmonise global fragmentation of regulation. Some loopholes remain for AI providers, governments and businesses alike.Read more ...

Krones: Opportunities in Emerging Markets and Managing Volatile Environments

Despite being affected by tight industry environments stock listed Krones Group is surprisingly unagitated. B2Bioworld enquired with Christoph Klenk, CEO of one of the largest beverage filling and packaging machinery companies in the world on strategies countering the current crisis and paving the path to growth. However, major risks are ahead, and success is not a foregone conclusion.Read more ...

Automated Valet Parking More Than Nice To Have

Automotive suppliers and car manufacturers are gearing up for autonomous driving. A challenging field is automated valet parking (AVP) which recently received green light by regulators. B2Bioworld asked Rolf Nicodemus at Bosch and AVP inventor about competitive propositions, testing experience outside Germany, use cases, and the challenges to go to market in varying cultural contexts.Read more ...

Making Money With Data

Steering Health Data For or By?

The User as Stakeholder, Expert, Citizen, Consumer, and Patient - Thomas Szucs, Chairman of Swiss Helsana Group on putting “big data” to work in insurance and healthcare Read more ...

Managers of Disease Meet Masters of Personal Health

Ursula B. Redeker, CEO of Roche Germany, about using digital tools to tap “big health data” of users, with an introduction by B2BioworldRead more ...

Businesses

Lab Shows: Where Is the Core Community?

Eurofins: “We have some of the biggest databases in the world…”

Philanthropy re-visited: Merck’s focus on Africa

Prospecting and Monitoring Distributors in Iran

Wacker Biotech B.V.: Catching up with renovation

Bayer AG: New stakes in stem cells

Cash in Agbio and Food Markets

Moving Plant Bioscience to Climate-friendly States

Corporate Compliance: Training the paper tiger to purr, show its teeth, or jump on

Personalised Medicine: Let’s be clear what it means

Skål! GM-beer served with eco-emotions

Novartis and Stem Cells

Stem Cell Research Now and in the Future - Viewed from GSK

Merck Life Science: Make or Break Drug Discovery and Biopharma

Mapei: Outlook on Construction Chemicals

Genetic Testing à la Myriad

Apropos Promaíz Argentina

Patient-centered Precision Care

ONEX gets a bargain – KraussMaffei re-structuring

ACHEMA and / or LABVOLUTION ?

editorial headlines

Hello Taxi! Do you understand me?

E-mobility and more: Resolving the Innovation Paradox

Monsanto’s agbiotech strategy

Industrial Bioscience: Solutions Marketing Never Dreamt of…

Abengoa Bioenergy: Heating up in USA to pounce Latin America and Europe

Being the Truffle Pig of Industries Worldwide

Roche Ethiopia: Build-up of an emerging market

Novartis: Adhering to Values Pays Off

Network intelligence for Lundbeck’s new drugs

No Mercy with Violators of Corporate Compliance

Novo Nordisk: Commercialising stem cells

Pfizer Embraces Regenerative Medicine

Sustainability refers to more than “green” or “bio-based”

Boehringer Ingelheim: Embryonic stem cells and animal models

MediGene Set to Implement Strategic Turnaround

Is that worth a dollar, or a million dollars?

Close-up: German National Center for Tumor Diseases